Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.35+0.10 (+1.21%)
Close on Nov 13, 2026Market cap $3.13BP/E –Yield –
Bausch Health Companies statistics
91 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 17, 2027 (estimated, after the close)
- Last ex-dividend date
- Nov 10, 2010
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 1.41
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 2.00
- 2.57
- EV / EBIT
- 17.85
- 19.31
- EV / FCF
- 11.94
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 1.49%
- 10.8%
- Shares Change (QoQ)
- 0.09%
- 0.50%
- Float
- 256M
- 49M
- Shares Held by Insiders
- 31.5%
- 11.7%
- Shares Held by Institutions
- 63.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 7M
- –
- Short Interest Change
- -10.1%
- -0.80%
- Short % of Float
- 2.89%
- 9.01%
- Short % of Shares Outstanding
- 1.98%
- 6.30%
- Days to Cover
- 1.24
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $9.04
- –
- 52-Week Low
- $4.33
- –
- 20-Day Moving Average
- $7.55
- –
- 50-Day Moving Average
- $6.57
- –
- 200-Day Moving Average
- $5.80
- –
- Average True Range (14)
- $0.36
- –
- Price Change (1 Week)
- 2.08%
- -1.15%
- Price Change (1 Month)
- 32.3%
- -4.87%
- Price Change (3 Months)
- 26.9%
- -21.0%
- Price Change (6 Months)
- 54.1%
- -20.6%
- Price Change (YTD)
- 20.1%
- -23.6%
- Price Change (1 Year)
- 20.3%
- -22.4%
- Price Change (3 Years)
- 23.0%
- -29.5%
- Price Change (5 Years)
- -68.4%
- -77.9%
- Price Change (10 Years)
- -52.4%
- -65.4%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 5M
- –
- Average Volume (90 Days)
- 3M
- –
- Relative Volume
- 0.67
- 0.70
- Relative Strength Index (14)
- 66.1
- 43.4
- Volatility (1 Year)
- 62.5%
- 80.1%
- Beta (5 Years)
- 1.00
- 1.07
MarginsIndustry
- Pretax Margin
- -3.18%
- -11.6%
- EBITDA Margin
- 21.6%
- -27.7%
- FCF Margin
- 16.8%
- -9.56%
Returns on capitalIndustry
- Return on Assets (ROA)
- -3.22%
- -40.6%
- Return on Invested Capital (ROIC)
- 5.47%
- -32.9%
- Return on Capital Employed (ROCE)
- 6.01%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.56
- 3.30
- Quick Ratio
- 1.06
- 2.39
- Debt / EBITDA
- 8.61
- 3.15
- Debt / FCF
- 11.07
- 4.65
- Net Debt / EBITDA
- 7.57
- 1.97
- Interest Coverage
- 0.78
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 10.8%
- 6.82%
- Net Income Growth (YoY)
- -332.3%
- -14.4%
- EPS Growth (YoY)
- -336.1%
- -12.3%
- FCF Growth (YoY)
- 70.3%
- 6.85%
- Revenue Growth (3Y CAGR)
- 8.11%
- 2.25%
- Revenue Growth (5Y CAGR)
- 5.04%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.42
- 0.40
- Revenue Per Employee
- $547.44K
- $429.29K
- Profits Per Employee
- -$41.43K
- -$689.41K
- Employee Count
- 20,300
- 74
- WACC
- 6.62%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$353.00M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- -$18.15B
- $17.76M
- Net Cash Per Share
- -$48.50
- $0.80
- Equity (Book Value)
- -$1.33B
- $53.89M
- Book Value Per Share
- -$3.55
- $1.50
- Tangible Book Value
- -$15.07B
- $27.13M
- Working Capital
- $2.66B
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$344.00M
- -$1.00M
- FCF Per Share
- $4.98
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -26.9%
- -21.8%
- FCF Yield
- 59.7%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $1.59B
- $2.90M
- Income Tax
- $475.00M
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 0.22
- 0.23
- Piotroski F-Score
- 6
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | BHC | S&P 500 | Difference | BHC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +41.8% | -3.0% | +44.8 pts | ||
| 3 months | +31.7% | -2.8% | +34.5 pts | ||
| Year to date | +20.1% | +11.5% | +8.7 pts | ||
| 1 year | +26.1% | +13.5% | +12.7 pts | ||
| 3 years | +27.9% | +77.7% | −49.8 pts | +8.5% | +21.1% |
| 5 years | -68.4% | +72.6% | −141.0 pts | -20.6% | +11.5% |
| 10 years | -53.6% | +308.2% | −361.8 pts | -7.4% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
7M BHC shares were sold short on Oct 30, 2026, down 10.1% from the previous report, or 2.89% of the shares available to trade. At recent volumes it would take 1.2 days to buy them back. Over the last 20 sessions, 37.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,409,975 | -10.1% | 5,993,110 | 1.2 |
| Oct 15, 2026 | 8,243,538 | -1.9% | 1,975,160 | 4.2 |
| Sep 30, 2026 | 8,404,206 | -2.6% | 1,739,421 | 4.8 |
| Sep 15, 2026 | 8,627,598 | +5.0% | 2,817,274 | 3.1 |
| Aug 31, 2026 | 8,219,742 | -2.3% | 2,767,283 | 3.0 |
| Aug 14, 2026 | 8,415,649 | +11.3% | 4,962,454 | 1.7 |
| Jul 31, 2026 | 7,563,382 | +2.6% | 5,064,885 | 1.5 |
| Jul 15, 2026 | 7,370,473 | +0.5% | 1,977,680 | 3.7 |
| Jun 30, 2026 | 7,332,632 | -1.5% | 3,907,788 | 1.9 |
| Jun 15, 2026 | 7,441,129 | +21.5% | 2,209,833 | 3.4 |
| May 29, 2026 | 6,124,091 | +2.7% | 1,604,043 | 3.8 |
| May 15, 2026 | 5,965,122 | -6.3% | 1,749,810 | 3.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?